首页 / 院系成果 / 成果详情页

Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo 期刊论文

编号：

7c2e32fc-bcf2-4cdc-ac60-84ffe43835a8
作者：

Luo, Lumeng#^[1]Lv, Minghe^[1];Zhuang, Xibing^[1];Zhang, Qi(张琪)^[1]Qiao, Tiankui(乔田奎)*^[1]
语种：

英文
期刊：

ONCOTARGETS AND THERAPY ISSN：1178-6930 2019 年 12 卷 (3805 - 3815)
收录：
关键词：

lung cancer whole tumor cell vaccine irradiation tumor antigen T cell
摘要：

Background: During the past decades, great efforts have been built to develop lung cancer vaccines. Whole tumor cell lysate (TCL) are ideal sources of antigens for cancer vaccine design, which however have limited efficacy due to insufficient immunogenicity. Recently, radiotherapy has been closely related to immunotherapy. Numerous studies have demonstrated the regulatory effect of irradiation (IR) on tumor immune response.
Purpose: To explore the immunogenicity modulation effect of IR on lung cancer cells.
Methods: RNA-sequence and qPCR assay was used to evaluate the change of tumor antigens expression after repeated X rays radiation on A549 cells. Vaccine based on TCL of irradiated Lewis lung cancer cells (IR-LLC) was established; therapeutic effect of TCL (IR-LLC) was examined in xenografted tumor model of mice. Flow cytometry was conducted to evaluate the rate of immune cells in spleen; ELISA was used to detect the level of cytokines in plasma. Immunohistochemistry was performed to evaluate the infiltrations of T-cell in tumor tissues; TIMER analysis was used to explore the correlations between tumor antigen expressions and the abundances of immune infiltrates.
Results: IR upregulated the expression of tumor antigens in A549 cells. Compared to the control group and unirradiated tumor cell vaccine, TCL(IR-LLC) had a significantly stronger anti-tumor effect in mice bearing with LLC xenografts. TCL(IR-LLC) significantly increased matured DCs and total CD4+ T cells but downregulated Tregs and PD-1+ CD8+ T cells in mice spleen; TCL(IR-LLC) vaccine upregulated the level of IFN-gamma and IL-4 while decreased IL-10 in serum; increased infiltrations of CD4+ T-cells and CD8+ T-cells were observed in the tumor issues of mice immunized with TCL(IR-LLC). Tumor antigens including FN1, MFGE8, MMP2, MYL9 may contribute to the enhanced T-cell response.
Conclusion: This study confirmed the immunogenicity modulation effect of IR in NSCLC cells, indicating IR might be an effective strategy to enhance the anti-tumor immunity of cancer cell vaccine.
推荐引用方式
GB/T 7714：

Luo Lumeng,Lv Minghe,Zhuang Xibing, et al. Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo [J].ONCOTARGETS AND THERAPY,2019,12:3805-3815.
APA：

Luo Lumeng,Lv Minghe,Zhuang Xibing,Zhang Qi,&Qiao Tiankui.(2019).Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo .ONCOTARGETS AND THERAPY,12:3805-3815.
MLA：

Luo Lumeng, et al. "Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo" .ONCOTARGETS AND THERAPY 12(2019):3805-3815.
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：8  下载次数：0

分享到：

浏览次数：8

下载次数：0

打印次数：0